Cara Therapeutics, Inc. (CARA) Q2 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

to Cara Therapeutic's second quarter 2023 earnings call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 1 on your telephone. To remove yourself from the queue, please press star 1 1 again. I would now like to hand the call over to Matt Murphy, Investor Relations. Please go ahead. Thank you, operator, and good afternoon. After market closed today, CARA issued a news release announcing the company's financial and operating results for the second quarter of 2023. Copies of this news release and the associated SEC filing can be found in the investor section of our website at www.caratherapeutics.com. Before we begin, let me remind you that during the course of this conference call, we will be making certain forward-looking statements about CARA and our programs based on management's current plans and expectations. These statements are being made under the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties. Actual results may differ materially due to various factors, and CARA undertakes no obligation to update or revise these statements publicly as a result of new information or future results or developments. Investors should read the risk factors set forth in CARES 10-K for the year ended December 31st, 2022, and any subsequent reports filed with the SEC, including its Form 10-Q for the quarter ended June 30th, 2023. With that said, I'd like to turn the call over to Chris Posner, CARES Chief Executive Officer. Chris? Thanks, Matt. Good afternoon, everyone, and thank you for joining our call. With me today are Ryan Maynard, our Chief Financial Officer, Dr. Joanna Consalves, our...